Asai J. What is new in the histogenesis of granulomatous skin diseases? J Dermatol. 2017; 44 (3): 297 303.
Terziroli Beretta-Piccoli B., Mainetti C., Peeters M.A., Laffitte E. Cutaneous granulomatosis: a comprehensive review. Clin Rev Allergy Immunol. 2018; 54 (1): 131 146.
Sibbald C., Reyd S., Alavi A. Necrobiosis lipoidica. Dermatol Clin. 2015; 33 (3): 343 360.
Kota S.K., Jammula S., Kota S.K. et al. Necrobiosis lipoidica diabeticorum: a case-based review of literature. Indian J Endocrinol Metab. 2012; 16 (4): 614 620.
Reid S.D., Ladizinski B., Lee K. et al. Update on necrobiosis lipoidica: a review of etiology, diagnosis, and treatment options. J Am Acad Dermatol. 2013; 69 (5): 783 791.
Boateng B., Hiller D., Albrecht H.P., Hornstein O.P. Cutaneous microcirculation in pretibial necrobiosis lipoidica. Comparative laser Doppler flowmetry and oxygen partial pressure determinations in patients and healthy probands. Hautarzt. 1993; 44 (9): 581 586.
Ngo B., Wigington G., Hayes K. et al. Skin blood flow in necrobiosis lipoidica diabeticorum. Int J Dermatol. 2008; 47 (4): 354 358.
Holland C., Givens V., Smoller B.R. Expression of the human erythrocyte glucose transporter Glut-1 in areas of sclerotic collagen in necrobiosis lipoidica. J Cutan Pathol. 2001; 28 (6): 287 290.
Shimanovich I., Erdmann H., Grabbe J. et al. Necrobiosis lipoidica in monozygotic twins. Arch Dermatol. 2008; 144 (1): 119 120.
Muller S.A., Winkelmann R.K. Necrobiosis lipoidica diabeticorum. A clinical and pathological investigation of 171 cases. Arch Dermatol. 1966; 93 (3): 272 281.
O’Toole E.A., Kennedy U., Nolan J.J. et al. Necrobiosis lipoidica: only a minority of patients have diabetes mellitus. Br J Dermatol.1999; 140 (2): 283 286.
Peyri J., Moreno A., Marcoval J. Necrobiosis lipoidica. Semin Cutan Med Surg. 2007; 26 (2): 87 89.
Erfurt-Berge C., Dissemond J., Schwede K. et al. Updated results of 100 patients on clinical features and therapeutic options in necrobiosis lipoidica in a retrospective multicentre study. Eur J Dermatol. 2015; 25 (6): 595 601.
Самсонов В.А., Бутов Ю.С. Липоидный некробиоз. В кн.: Клиническая дерматовенерология: в 2 т. / под ред. Ю.К. Скрипкина, Ю.С. Бутова. М.: ГЭОТАР-Медиа, 2009. Т.2. С.511 521.
Дифференциальная диагностика кожных болезней / Беренбейн Б.А., Студницин А.А. и др.; под ред. Б.А. Беренбейна, А.А. Студницина. М.: Медицина,1989. 672 С.
Stanway A., Rademaker M., Newman P. Healing of severe ulcerative necrobiosis lipoidica with cyclosporin. Australas J Dermatol. 2004; 45 (2): 119 122.
Santos-Juanes J., Galache C., Curto J.R. et al. Squamous cell carcinoma arising in long-standing necrobiosis lipoidica. J Eur Acad Dermatol Venereol. 2004; 18 (2): 199 200.
Lim C., Tschuchnigg M., Lim J. Squamous cell carcinoma arising in an area of long-standing necrobiosis lipoidica. J Cutan Pathol. 2006; 33 (8): 581 583.
Clement M., Guy R., Pembroke A.C. Squamous cell carcinoma arising in long-standing necrobiosis lipoidica. Arch Dermatol. 1985; 121 (1): 24 25.
Ryan C., Amor K.T., Menter A. The use of cyclosporine in dermatology: Part II. J Am Acad Dermatol. 2010; 63 (6): 949 972.
Schäcke H, Döcke W-D, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther. 2002; 96 (1): 23 43.
Harris E, Tiganescu A, Tubeuf S, Mackie SL. The prediction and monitoring of toxicity associated with long-term systemic glucocorticoid therapy. Current Rheumatology Reports 2015; 17 (6): 513. (10.1007/s11926-015-0513-4)
Liu X.X., Zhu X.M., Miao Q. et al. Hyperglycemia induced by glucocorticoids in non-diabetic patients: a meta-analysis. Ann Nutr Metab. 2014; 65 (4): 324 332.
Rafacho A., Ortsäter H., Nadal A., Quesada I. Glucocorticoid treatment and endocrine pancreas function: implications for glucose homeostasis, insulin resistance and diabetes. J Endocrinol. 2014; 223 (3): R49 R62.
Цветкова Г.М., Мордовцева В.В., Вавилов А.М., Мордовцев В.Н. Патоморфология болезней кожи. М.: Медицина, 2003. 496 с.
Verrotti A., Chiarelli F., Amerio P. et al. Necrobiosis Lipoidica Diabeticorum in Children and Adolescents: A Clue for Underlying Renal and Retinal Disease. Pediatr Dermatol. 1995; 12 (3): 220 223.
Wu S.C., Driver V.R., Wrobel J.S., Armstrong D.G. Foot ulcers in the diabetic patient, prevention and treatment. Vasc Health Risk Manag. 2007; 3 (1): 65 76.
Goette D.K. Resolution of necrobiosis lipoidica with exclusive clobetasol propionate treatment. J Am Acad Dermatol. 1990; 22 (5 Pt 1): 855 856.
Marcoval J., Gómez-Armayones S., Valentí-Medina F. et al. Necrobiosis lipoidica: a descriptive study of 35 cases. Actas Dermosifiliogr. 2015; 106 (5): 402 407.
Özkur E., Hasçiçek S.Ö., Altunay İ.K. Atypical presentation of necrobiosis lipoidica in a pediatric patient. Pediatr Dermatol. 2019; 36 (1): e31 e33.
Лезвинская Е.М., Шамаева И.В., Ломовцева О.Б. Клинические и диагностические особенности липоидного некробиоза. Российский журнал кожных и венерических болезней. 2000; 4: 22 27.
Tong L.X., Penn L., Meehan S.A., Kim R.H. Necrobiosis lipoidica. Dermatol Online J. 2018; 24 (12): 13030/qt0qg3b3zw.
Поляков В.А. Мелкоузелковая форма липоидного некробиоза. Вестник дерматологии и венерологии. 1983; 6: 62 63.
Yahya H.Necrobiosis Lipoidica in a nigerian woman report of a case. Niger J Clin Pract. 2019; 22 (11): 1626 1628.
Patsatsi A., Kyriakou A., Sotiriadis D. Necrobiosis lipoidica: early diagnosis and treatment with tacrolimus. Case Rep Dermatol. 2011; 3 (1): 89 93.
Binamer Y., Sowerby L., El-Helou T. Treatment of ulcerative necrobiosis lipoidica with topical calcineurin inhibitor: case report and literature review. J Cutan Med Surg 2012; 16 (6): 458 461
Clayton T.H., Harrison P.V. Successful treatment of chronic ulcerated necrobiosis lipoidica with 0.1% topical tacrolimus ointment. Br J Dermatol. 2005; 152 (3): 581 582.